173 related articles for article (PubMed ID: 34240162)
1. Rare Causes of Hypercalcemia: 2021 Update.
Motlaghzadeh Y; Bilezikian JP; Sellmeyer DE
J Clin Endocrinol Metab; 2021 Oct; 106(11):3113-3128. PubMed ID: 34240162
[TBL] [Abstract][Full Text] [Related]
2. Clinical review: Rare causes of hypercalcemia.
Jacobs TP; Bilezikian JP
J Clin Endocrinol Metab; 2005 Nov; 90(11):6316-22. PubMed ID: 16131579
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy).
Sato K
Endocr J; 2008 Dec; 55(6):959-66. PubMed ID: 18614854
[TBL] [Abstract][Full Text] [Related]
4. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
Chukir T; Liu Y; Hoffman K; Bilezikian JP; Farooki A
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1115-23. PubMed ID: 31841590
[TBL] [Abstract][Full Text] [Related]
6. Association of primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell renal carcinoma.
Gomes Lda S; Kulak CA; Costa TM; Vasconcelos EC; Carvalho Md; Borba VZ
Arch Endocrinol Metab; 2015 Feb; 59(1):84-8. PubMed ID: 25926120
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
8. Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer.
Szymanski JJ; Otrock ZK; Patel KK; Scott MG
Clin Chim Acta; 2016 Jan; 453():190-3. PubMed ID: 26706788
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia of Malignancy and Colorectal Cancer.
Galindo RJ; Romao I; Valsamis A; Weinerman S; Harris YT
World J Oncol; 2016 Feb; 7(1):5-12. PubMed ID: 26998187
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol-mediated hypercalcemia: causes and course in 101 patients.
Donovan PJ; Sundac L; Pretorius CJ; d'Emden MC; McLeod DS
J Clin Endocrinol Metab; 2013 Oct; 98(10):4023-9. PubMed ID: 23979953
[TBL] [Abstract][Full Text] [Related]
15. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
[TBL] [Abstract][Full Text] [Related]
16. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma.
Srivastava T; Kats A; Martin TJ; Pompolo S; Alon US
Pediatr Nephrol; 2011 May; 26(5):799-803. PubMed ID: 21161280
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia with nephrocalcinosis and impaired renal function due to increased Parathyroid hormone secretion at onset of childhood acute lymphoblastic leukemia.
Lankisch P; Kramm CM; Hermsen D; Wessalowski R
Leuk Lymphoma; 2004 Aug; 45(8):1695-7. PubMed ID: 15370228
[TBL] [Abstract][Full Text] [Related]
20. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
